Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
- PMID: 35508952
- PMCID: PMC9081986
- DOI: 10.5217/ir.2021.00115
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
Abstract
Inflammatory bowel disease (IBD) has become a global disease. As IBD is a chronic disease that can result in remarkable morbidity and disability, estimation and understanding the disease burden of IBD is imperative to prepare adequate health care systems. However, variations in IBD incidence or prevalence may reflect differences in the distribution, and there are regional disparities in Asia with a large population of approximately 4.6 billion in 2020, which is equivalent to 60% of the total world population. Although comprehensive understanding of the epidemiology of IBD in Asian countries is difficult, this review includes updated data regarding the incidence and prevalence of IBD and the estimated disease burden in Asia.
Keywords: Asia; Epidemiology; Inflammatory bowel disease.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Aniwan S, Park SH, Loftus EV., Jr Epidemiology, natural history, and risk stratification of Crohn’s disease. Gastroenterol Clin North Am. 2017;46:463–480. - PubMed
-
- Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769–2778. - PubMed
-
- Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
